Cita APA

Isakoff, M. S., Goldsby, R., Villaluna, D., Krailo, M. D., Hingorani, P., Collier, A., . . . Janeway, K. A. (2018). A Phase II Study of Eribulin in Recurrent or Refractory Osteosarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer.

Citación estilo Chicago

Isakoff, Michael S., et al. "A Phase II Study of Eribulin in Recurrent or Refractory Osteosarcoma: A Report From the Children’s Oncology Group." Pediatr Blood Cancer 2018.

Cita MLA

Isakoff, Michael S., et al. "A Phase II Study of Eribulin in Recurrent or Refractory Osteosarcoma: A Report From the Children’s Oncology Group." Pediatr Blood Cancer 2018.